cheronis john (17 Ergebnisse)

Paperback. Zustand: Very Good. 1. It's a well-cared-for item that has seen limited use. The item may show minor signs of wear. All the text is legible, with all pages included. It may have slight markings and/or highlighting.

Zustand: Good. Good condition. A copy that has been read but remains intact. May contain markings such as bookplates, stamps, limited notes and highlighting, or a few light stains.

Zustand: Good. Former library copy. Pages intact with minimal writing/highlighting. The binding may be loose and creased. Dust jackets/supplements are not included. Includes library markings. Stock photo provided. Product includes identifying sticker. Better World Books: Buy Books. Do Good.

Hardcover. Zustand: Good. No Jacket. Pages can have notes/highlighting. Spine may show signs of wear. ~ ThriftBooks: Read More, Spend Less.

Hardcover. Zustand: Good. No Jacket. Pages can have notes/highlighting. Spine may show signs of wear. ~ ThriftBooks: Read More, Spend Less.

Zustand: Good. 401 pp., Hardcover, ex library, else text clean and binding tight. - If you are reading this, this item is actually (physically) in our stock and ready for shipment once ordered. We are not bookjackers. Buyer is responsible for any additional duties, taxes, or fees required by recipient's country.

gebundene Ausgabe. Zustand: Gut. XXVIII, 410 Seiten; Der Erhaltungszustand des hier angebotenen Werks ist trotz seiner Bibliotheksnutzung sehr sauber und kann entsprechende Merkmale aufweisen (Rückenschild, Instituts-Stempel.). In ENGLISCHER Sprache. Sprache: Englisch Gewicht in Gramm: 765.

Zustand: New. In.

Paperback. Zustand: Brand New. reprint edition. 429 pages. 9.00x1.00x6.30 inches. In Stock.

Hardcover. Zustand: gut. 2000. This volume is the first to combine latest information on viral, microbial and cellular proteolytic enzymes as potential targets for human therapeutics. Proteases control a large array of physiological reactions, and are involved in a variety of pathological processes for which effective medications are currently needed and/or being sought after. Although protease inhibitors have been investigated for many years, few have been employed therapeutically. Recent break- through by HIV protease inhibitors as therapeutic drugs has re-encouraged the search for inhibitors of other proteolytic enzymes. Klaus von der Helm, who described the first viral protease has brought leading experts together to discuss not only the success and problems of clinical use and continuing prospects, but to review further potential drug targets. This volume provides detailed information and evaluations of key viral, bacterial, fungal, and cellular proteases as potential future drug candidates. TOC: I: HIV Protease Inhibitors (PI).- II: Other Viral (Non-HIV) Protease Inhibitors.- III: (Non-Viral) Proteases Involved in Diseases. Reihe/Serie Handbook of Experimental Pharmacology ; Vol.140 Sprache englisch Maße 155 x 235 mm Einbandart gebunden Medizin Pharmazie Pharmakologie Arzneien Medikamente Arzneimittel Chemotherapie Chemotherapy drug design Pharmakologe Protease protease inhibitors Proteasen ISBN-10 3-540-66118-2 / 3540661182 ISBN-13 978-3-540-66118-4 / 9783540661184 In englischer Sprache. 401 pages. 24,1 x 15,9 x 2,5 cm.

Zustand: New. In.

Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - Proteolytic enzymes and their natural antagonists, the protease inhibitor pro teins, play a crucial role in the physiology and pathology of living organisms including humans. Remark able advantages revealed their wide functional context. Proteases digest food proteinase in the digestive tract and liberate poly peptide hormones, stimulating gastric and pancreatic secretion. Proteases are involved during fertilization in sperm - egg interaction, ovulation, ovum implantation and parturition. Proteases of the renin-angiotensin and kallikrein-kinin systems act synergistically to generate blood pressure regu lating polypeptides. In wound healing a battery of proteases is involved in the proteolytic cascades of clotting, fibrinolysis and tissue repair.Another battery of very different proteases directs the immune defense via several routes, i.e. complement activation, antigen presentation, the generation of chemokines and chemotaxins directing phagocytes to the site of injury or infection and the generation of cell-stimulating factors such as cytokines regulating the inflam matory response of the organism.Granzymes contribute to the toxicity of lym phocytes or killer cells,caspases regulate physiological cell death and calpains intracellular signaling cascades.The energy-dependent proteasome-ubiquitin system controls highly efficientl y the activity or level of intracellular proteins, including cell-cycle regulators, transcription and signal transduction factors, oncoproteins and short-lived metabolic enzymes.And this listing is far from complete.

Taschenbuch. Zustand: Neu. Proteases as Targets for Therapy | Klaus Helm (u. a.) | Taschenbuch | xxviii | Englisch | 2012 | Springer | EAN 9783642630231 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.

Hardcover. Zustand: Very Good. No Jacket. 1st Edition. First Edition / First Print. Hardback copy in dark blue cloth boards with gold gilt lettering to front and spine, no dustjacket. 498pp. B/w diagrams throughout. 'International Atomic Weights' table to endpapers. Not library copy, name/date in ink to front pastedown. (36/6).

Hardcover. Zustand: Brand New. 410 pages. 9.50x6.25x1.00 inches. In Stock.

Zustand: Sehr gut. Zustand: Sehr gut | Seiten: 410 | Sprache: Englisch | Produktart: Bücher | Keine Beschreibung verfügbar.

Zustand: New. This volume is the first to combine latest information on viral, microbial and cellular proteolytic enzymes as potential targets for human therapeutics. Proteases control a large array of physiological reactions, and are involved in a variety of pathologica.